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This article systematically reviews the literature on the impact of collaboration between pharmacists and general practitioners and
describes its effect on patients’ health. A systematic literature search provided 1041 articles. After first review of title and abstract, 152
articles remained. After review of the full text, 83 articles were included. All included articles are presented according to the following
variables: (i) reference; (ii) design and setting of the study; (iii) inclusion criteria for patients; (iv) description of the intervention; (v)
whether a patient interview was performed to involve patients’ experiences with their medicine-taking behaviour; (vi) outcome; (vii)
whether healthcare professionals received additional training; and (viii) whether healthcare professionals received financial
reimbursement. Many different interventions are described where pharmacists and general practitioners work together to improve
patients’ health. Only nine studies reported hard outcomes, such as hospital (re)admissions; however, these studies had different results,
not all of which were statistically significant. Randomized controlled trials should be able to describe hard outcomes, but large patient
groups will be needed to perform such studies. Patient involvement is important for long-term success.
Introduction
To provide best pharmaceutical care practice, it is impor-
tant that all relevant persons are involved and work
together as a healthcare team [1, 2]. As a result, healthcare
providers should have a complete patient and medical
record. Besides medical information from healthcare pro-
viders, a consultation round with the patient is also neces-
sary to determine patients’ problems and patients’ needs.
Active participation of patients during treatment could
help to achieve better patient outcomes [3, 4]. In primary
care, the triangle of the pharmacist–general practitioner
(GP)–patient is important for providing optimal pharma-
ceutical care. According to the definition of Cipolle et al.,
pharmaceutical care is ‘a patient-centered practice in
which the practitioner assumes responsibility for a
patient’s drug-related needs and is held accountable for
this commitment’ [5].
An important tool for pharmaceutical care is regular
medication reviews or medication reconciliation next to
the assessment of patient needs and the development of a
care plan. A medication review is defined as ‘a structured,
critical examination of a patient’s medicines with the
objective of reaching an agreement with the patient about
treatment, optimizing the impact of medicines, minimizing
the number of medication-related problems and reducing
waste’ [6]. Medication reconciliation is defined as ‘the
process of obtaining and maintaining a complete and
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accurate list of the current medication use of a patient
across healthcare settings’ [7]. In 2002, the Medicines
Partnership defined four levels of medication review [6]
(Figure 1). An ad hoc review (level 0) consists of an isolated
question to a patient. A prescription review (level 1) is a
review of a patient’s medicine by a pharmacist. A treat-
ment review (level 2) requires cooperation between
pharmacist and GP (or medical specialist) to review a
patient’s medicines with the patient’s full notes. Finally, a
clinical medication review (CMR; level 3) requires face-to-
face cooperation between pharmacist and/or GP and the
patient in order to review a patient’s medicines and con-
ditions. When performing a higher level of medication
review, cooperation must increase. In 2008, the four levels
were reviewed and redefined to three types in order to
focus on the purpose of medication review [8]. One impor-
tant reason was that medicines use review (MUR), a new
development in medication review services, did not fit
within the previously defined levels of medication review.
A MUR is conducted with the patient (level 3) but without
access to the patient’s full notes (level 2). In this new clas-
sification, prescription review (type 1), concordance and
compliance review (type 2) and clinical medication review
(type 3) are defined (Table 1) [8]. However, we believe not
all different kinds of medication review are covered within
these new defined types of medication reviews, e.g. the
former level 2, treatment review, where a pharmacist coop-
erates with a GP to review the patient’s medicines with the
patient’s full notes. Several classifications of medication
review activities are being used but none covers all differ-
ent activities. One similarity is that both the highest level
and/or type of medication review requires the patient’s
presence. We therefore decided to focus on the participa-
tion of the patient.
So far, there are no systematic reviews available that
compare the different types of cooperation between
family doctors and pharmacists and their impact on
patient outcomes. This article systematically reviews the
literature on the impact of collaboration between pharma-
cists and GPs and describes their outcomes on patients’
health.
Methods
A systematic literature search was performed in the data-
bases PubMed and Embase (period until 16 June 2011)
with keywords described in Table 2. Abstracts and articles
were reviewed by two authors independently (M.M.E.G
and J.J.deG.). Articles were first reviewed based on title and
abstract (n = 1041) and second on full text (n = 152). Only
English and Dutch written articles were included. Full-text
articles were excluded based on language (n = 2), lack of
cooperation (n = 11), lack of patient outcomes (n = 41),
short communication, e.g. letter, summary or abstract (n =
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articles were included, five from references from other
articles and two that were not available in the databases
at time of the literature search. In total, 83 articles were
included (Figure 2). The measure of agreement between
the two reviewers, defined as Cohen’s kappa (k), was cal-
culated using SPSS 18.0.3.
Results
The two authors, who reviewed the titles and abstracts,
reached strong agreement (k = 0.766). All included articles
after review of full text (n = 83) are presented in Table 3
according to the following variables: (i) reference; (ii)
design and setting of the study; (iii) inclusion criteria for
patients; (iv) description of the intervention; (v) whether
a patient interview was performed to involve patients’
experiences with their medicine-taking behaviour; (vi)
outcome; (vii) whether healthcare professionals received
additional training; and (viii) whether healthcare profes-
sionals received financial reimbursement. Articles are
arranged in alphabetical order.
The 83 included articles describe results from 77
studies. Most studies were performed in Europe (n = 40),
followed by the USA/Canada (n = 19) and Australia/New
Zealand (n = 18). A majority of studies (n = 60) describe
patient involvement using a patient interview or consulta-
tion (either at home or at the pharmacy/GP practice).
About one-third of the studies (26 of 77) provided infor-
mation on additional training, mostly for participating
pharmacists. Only 11 studies reported financial reimburse-
ment for participating healthcare providers. The amounts
differed and were not always mentioned.
Studies with a high level of evidence, such as random-
ized controlled trials, showed more significant results
when compared with studies having a lower level of evi-
dence, such as retrospective observational studies. Not all
studies were able to conclude with hard outcomes, such as
decrease in hospital admissions or costs. Only nine studies
reported outcomes on hospital admissions. When we
focused more on these studies,we found some differences.
Farris et al. [9] showed a nonsignificant decrease in hospital
admissions. A single-group pre–post design was used,
and 199 patients were included (no power calculation
was performed). Each primary healthcare team (PHCT)
received training, but team pharmacists were generally not
patients’ dispensing pharmacists. An average of 3.9 issues
were defined per patient, and an average of 59% of issues
were resolved. However, these numbers showed large dif-
ferences between the six PHCTs. Six studies used a ran-
domized controlled trial (RCT) design. Graffen et al. [10]
showed no differences in hospitalization rates among 402
included patients (determined by power calculation). No
additional training was provided and no patient interview
performed. Hospitalizations were determined by asking
patients. Holland et al. [11] found a statistically significant
increase in hospital admissions. A total of 872 patients
were included (determined by power calculation). Pharma-
cists received a 2 day training course. Leendertse [12]
found a nonsignificant decrease in medication-related
Table 1















Type 1: prescription review Address technical issues relating to
prescription
No Possibly Possibly No Medicines
Type 2: concordance and
compliance review
Address issues relating to patient’s
medicine-taking behaviour
Usually Possibly Yes Yes Medicines use
Type 3: clinical medication
review
Address issues relating to the
patient’s use of medicines in the
context of their clinical condition
Yes Yes Yes Yes Medicines and condition
Table 2
Keywords used for literature search
‘Pharmacists’ [Mesh] OR ‘Pharmaceutical Services’[Mesh] OR
‘pharmaceutical care’ [All Fields] OR pharmaceutical service* [All Fields]
OR ‘pharmacists’ [All Fields] OR ‘pharmacist’ [All Fields] OR
pharmaceutical practice* [All Fields]
AND
‘Physicians, Family’ [Mesh] OR ‘Family Practice’ [Mesh] OR ‘family
practice’ OR ‘general practice’ OR general practitioner* OR family
practitioner*
AND
‘Patient Care’ [Mesh] OR ‘Interprofessional Relations’ [Mesh] OR
cooperation [All Fields] OR ‘referral and consultation’ [Mesh Terms] OR
‘consultation’ [All Fields] OR ‘patient care’ [All Fields] OR review*
AND
medical record* OR prescription record* OR ‘pharmaceutical care’ OR
medication
*used to search multiple options at the same time (singular vs. plural).
M. M. E. Geurts et al.
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hospital admissions; however, the intervention did show a
statistically significant result for patients with five or more
diseases. In this RCT, 674 patients were included (aim
14 200 based on power calculation). Pharmacists received
additional training. Lenaghan et al. [13] found no differ-
ences in hospital admissions among 136 included patients
(aim 164 based on power calculation). Pharmacists did not
receive additional training but were experienced in per-
forming home medicines reviews (HMRs). Makowsky et al.
[14] found a statistically significant decrease in hospital
admissions after 3 but not after 6 months. A total of 452
patients were included (aim 650 based on power calcula-
tion). The intervention was performed by experienced
pharmacists who did not receive additional training. Naza-
reth et al. [15] found no differences in hospital admissions
among 362 included patients (aim 390 based on power
calculation). No additional training was provided for par-
ticipating healthcare providers. Two cohort studies per-
formed by Roughead et al. [16, 17] showed a statistically
significant decrease in hospitalization rates for specific
patient groups. Their first study included 273 patients
exposed to an HMR and showed a 45% reduction in hos-
pitalization for heart failure patients [16]. Their second
study included 816 patients exposed to an HMR and
showed 79% reduction in hospitalization for warfarin-
associated bleeding [17]. Both studies were performed by
experienced pharmacists, and no additional training was
provided.
Other significant results found were decreases in
number of drug-related problems, improved prescribing
of medication, improved quality of life scores, improved
medication appropriateness index scores, increased com-
pliance and patient knowledge, and improved clinical
values, e.g. cholesterol levels. Most studies described
positive outcomes on satisfaction. Healthcare providers
and patients were satisfied when they were involved in
projects. Studies also showed that when cooperation
between healthcare providers and patients occurred, more
drug-related problems were defined and solved.
Discussion
A recent Cochrane review focused on health-related
outcomes of clinical pharmacy services [18]. Pharmacist
interventions resulted in improvement in most clinical out-
comes, but these were not always statistically significant.
The Cochrane review only describes pharmacist interven-
tions, whereas our review focuses on interventions with
cooperation between pharmacists and GPs.













76 excluded based on full text
- language (2)
- lack of cooperation (11)
- lack of patient outcomes (41)
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Only nine studies report hard outcomes, such as hospi-
tal (re)admissions [9–17]. Three studies show a significant
decrease in hospital (re)admissions [14, 16, 17], and one
study shows an increase in hospital admissions [11]. The
intervention described by Holland et al. is performed by a
review pharmacist [11].Also, the intervention by Farris et al.
[9] was not performed by the patients’ own pharmacist,
whereas the other seven studies did include cooperation
between the patients’ own pharmacist and GP. All studies
with no differences in hospital admissions provided no
additional training to pharmacists [10, 13, 15]; however,
one study did mention that the intervention was per-
formed by experienced pharmacists [13]. Graffen et al. [10]
determined hospitalization rates by asking patients, which
could result in recall bias. Other studies did provide
additional training to pharmacists or mentioned that phar-
macists were experienced. This could mean that the phar-
macists involved in the selected studies were not able to
perform an adequate medication review or medication
reconciliation without additional training. Not all studies
managed to include sufficient patient numbers necessary
according to their power calculation. Two studies did
report a decrease in hospital admissions, which could be
significant after including higher patient numbers [12, 14]
A subanalysis from Leendertse et al. [12] did show a signifi-
cant decrease in medication-related hospital admissions
for patients with 5 diseases. In order to retrieve hard
outcomes, such as hospital (re)admissions, randomized
clinical trials with large numbers of patients are needed. In
most studies, numbers are too small to be able to study
hard outcomes. Also, the level of cooperation and commu-
nication between healthcare providers is important.
Denneboom et al. [19] performed a study using level
2 medication review and concluded that feedback in
personal contact led to significantly more medication
changes when compared with written feedback. When
there is personal contact, healthcare providers can moti-
vate their opinion on possible medication changes and,
together, might choose a different intervention than they
originally had suggested instead of rejecting the proposed
intervention outright. When the patient is also involved,
the intervention will have a higher chance of long-term
success. When patients agree with the proposed interven-
tion, they will be more motivated to change [4, 20–22].The
quality of collaboration is also important. Isetts et al. [23]
performed a quality assessment of therapeutic determina-
tions made by pharmacists. Decisions made by healthcare
providers were found to be clinically credible based on the
evaluations and comments of a peer review panel. When
pharmaceutical care practitioners collaborate with physi-
cians to provide drug therapy management services, this
may help to reduce drug-related morbidity and improve
therapeutic outcomes. Several classifications of medica-
tion review activities are used, but none of the classifica-
tion systems is able to cover all different kinds of activities.
In order to compare different activities, it is important to
develop one classification system that can be used for
all different activities performed throughout the whole
world.
Most studies performed focused on elderly patients
with multiple morbidities using multiple medicines
(polypharmacy). These patients are at higher risk of com-
plications and would benefit most from a periodic CMR
[24, 25]. In many countries, clinical pharmacologists are
also involved in CMRs; these studies were not included
in this review, because the focus is on pharmacists and
GPs as healthcare providers, with whom patients have a
relationship.
Besides study design and patient outcomes, we looked
at additional training for healthcare providers and financial
reimbursement. Performing services such as medication
review or medication reconciliation takes time. When per-
formed at a higher level, time investment will increase. We
question whether all healthcare providers have sufficient
skill and experience to perform these services, knowing it
involves complex patients with multiple morbidities and
polypharmacy. In about one-third of the included studies,
additional training was provided to participating health-
care providers, usually for pharmacists.This training usually
concerned education about specific diseases and commu-
nication skills. Twelve studies mention that they did not
provide additional training, but the studies were per-
formed by accredited and experienced (clinical) pharma-
cists. Of these studies, six were performed in Australia,
where the service called home medicines review (HMR)
can only be performed by accredited pharmacists who are
reimbursed for their services. Australia is well known for
the development and implementation of HMRs.
Some studies focused on cost-effectiveness of medica-
tion review services, but none could show significant
results.A recent study by Perez et al. [26] showed economic
evaluations of clinical pharmacy services from 2001 to
2005. A median benefit-to-cost ratio of 4.81:1 was found,
meaning that for every $1 spent a $4.81 reduction in costs
or other economic benefits was achieved. When other
healthcare providers besides pharmacists, e.g. GPs, are
involved, costs of the intervention will increase without
knowing what this means for the achieved benefits. More
research on cost-effectiveness of multidisciplinary inter-
ventions is necessary.
The strength of this article is its use of a systematic
literature search. However, we did find five relevant articles
outside the performed search, which may mean we missed
other articles. One reason for this could be that certain
articles do not have well-defined keywords or that coop-
eration is not explicitly mentioned in the title or abstract.
We excluded two articles based on their language (Norwe-
gian and French). We do not believe this influenced our
results.
We recommend that future research should include a
large randomized clinical trial with high patient numbers
focused on hard outcomes,e.g.hospital (re)admissions and
Cooperation between pharmacist and general practitioner
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cost-effectiveness. With such a study, healthcare providers
would be able to show their professional skills and how
they can provide benefit to patients at high risk. This will
make it easier to determine the necessary additional skills
and proper reimbursement for time spent.
Conclusions
Many different interventions are described where pharma-
cists and GPs work together to improve patients’ health.
Besides results on patient satisfaction, drug-related prob-
lems, quality of life and clinical values, fewer studies report
hard outcomes, and results are not all comparable. Ran-
domized controlled trials should be able to describe hard
outcomes, but large patient groups will be needed to
perform such studies. Patient involvement is important for
motivation to change and for a long-term effect of the
proposed intervention.
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